December 11, 2017 by Bill Schiffner
John Hammergren, McKesson, Paul Julian
2017, Issue 12-11-2017, Issues, News
SAN FRANCISCO — Paul Julian, executive vice president and group president at McKesson Corp., is slated to retire at the end of the year. Julian currently has senior operating responsibility for McKesson’s domestic and international Distribution Solutions businesses, including pharmaceutical distribution, medical-surgical distribution, specialty health and retail pharmacy systems and automation. As president of McKesson
June 5, 2017 by Jeffrey Woldt and Chain Drug Review
Celesio, CoverMyMeds, Health Mart, Jeffrey Woldt, McKesson, Paul Julian, Rexall Health, Uniprix
2017, Issue 06-05-2017, Issues, Opinion

Members of McKesson Corp.’s senior management know what it takes to be a major player in the global health care marketplace, and they are moving decisively to ensure that going forward the company remains a dominant force in the sector. McKesson in recent years has made a number of strategic acquisitions that deepen and extend
May 30, 2017 by Jeffrey Woldt
Jeffrey Woldt, McKesson Corp., Paul Julian, Uniprix
Retail News

SAN FRANCISCO — Members of McKesson Corp.’s senior management know what it takes to be a major player in the global health care marketplace, and they are moving decisively to ensure that going forward the company remains a dominant force in the sector. McKesson in recent years has made a number of strategic acquisitions that
January 16, 2017 by Mark Baumgartner and Chain Drug Review
Domenic Pilla, John Hammergren, Jürgen Schreiber, McKesson, McKesson Canada, Paul Julian, Rexall Health, Shoppers Drug Mart
2017, Issue 01-16-2017, Issues, News
TORONTO — Domenic Pilla has been appointed chief executive officer of McKesson Canada. Pilla now guides Canada’s largest distributor of pharmaceuticals and medical supplies and oversees the integration of Rexall Health, which McKesson Canada acquired in late December. McKesson Canada picked up about 470 retail pharmacies in the Rexall deal. Pilla reports to Paul Julian,
December 29, 2016 by Chain Drug Review
Daryl Katz, Domenic Pilla, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Paula Keays, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News

SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will
December 14, 2016 by Chain Drug Review
Competition Bureau of Canada, Katz Group Canada, McKesson, Paul Julian, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News

SAN FRANCISCO — McKesson Corp. has been given the green light from the Competition Bureau of Canada to finalize its $2.2 billion acquisition of drug chain Rexall Health. McKesson said Wednesday that under the consent agreement it signed with the bureau, it must sell a total of 26 Rexall drug stores in Alberta, British Columbia,
December 12, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, McKesson, McKesson Canada, Paul Julian, Paula Keays
2016, Issue 12-12-2016, Issues, News
MONTREAL — Sixteen-year company veteran Paula Keays has been promoted to president of McKesson Canada. Keays had been senior vice president of pharmaceutical distribution and operations. She fills the vacancy that was created by the late-summer departure of Alain Champagne, who joined sales training and development firm Optimé International as a partner and chief executive
November 28, 2016 by Chain Drug Review
Alain Champagne, McKesson Canada, Paul Julian, Paula Keays, pharmaceutical distribution
Business, Featured Articles, Leading Headlines, Retail News

ST. LAURENT, Quebec — McKesson Canada has promoted pharmaceutical distribution chief Paula Keays to president. Keays, senior vice president of pharmaceutical distribution and operations, takes the reins as president effective immediately, McKesson Canada said Monday. She fills the vacancy created by the late summer departure of Alain Champagne, who joined sales training and development firm Optimé
March 14, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
2016, Issue 03-14-2016, Issues, News

TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,
March 2, 2016 by John Schultz and Chain Drug Review
Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News

SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more
September 28, 2015 by Mark Baumgartner and Chain Drug Review
Celesio, Marc Owen, McKesson, McKesson Distribution Solutions, Paul Julian, pharmaceutical distribution, UDG Healthcare
2015, Issue 09-28-2015, Issues, News
SAN FRANCISCO — McKesson Corp. has agreed to purchase the pharmaceutical distribution division of Dublin, Ireland-based UDG Healthcare PLC for about $466 million. The deal — which is contingent upon a vote of approval from UDG Healthcare shareholders and clearance from European Union regulators — would give McKesson distribution channels across the Republic of Ireland
September 18, 2015 by Chain Drug Review
Celesio, Marc Owen, McKesson, Paul Julian, Peter Gray, pharmaceutical distribution, Sainsbury, UDG Healthcare
Business, Leading Headlines, Pharmacy, Supplier News

SAN FRANCISCO — McKesson Corp. plans to acquire the pharmaceutical distribution division of Dublin, Ireland-based UDG Healthcare plc for about $466 million. McKesson said early Friday that under the deal it will purchase United Drug and United Drug Sangers, leading wholesale operations across the Republic of Ireland and Northern Ireland, respectively; TCP, a home health
June 9, 2015 by Chain Drug Review and Chain Drug Review
2015 Nexus Award for Lifetime Achievement, Center for Healthcare Supply Chain Research, HDMA, Healthcare Distribution Management Association, John Gray, John Hammergren, Karen Ribler, McKesson, Paul Julian
Leading Headlines, Pharmacy, Supplier News

ARLINGTON, Va. — McKesson Corp. executive Paul Julian has received the 2015 Nexus Award for Lifetime Achievement from the Healthcare Distribution Management Association’s Center for Healthcare Supply Chain Research and Genentech Inc. HDMA said Tuesday that Julian, executive vice president and group president at McKesson, was presented the award this week at the 2015 HDMA
March 16, 2015 by Chain Drug Review
Bansi Nagji, Brian Tyler, Celesio, John Hammergren, McKesson, Paul Julian, pharmaceutical distribution
2015, Issue 03-16-2015, News
SAN FRANCISCO — Brian Tyler has been promoted to president of North American pharmaceutical distribution and services at McKesson Corp. The company also has hired Bansi Nagji to take over Tyler’s previous post as executive vice president of corporate strategy and business development. As president of North American pharmaceutical distribution, Tyler takes on a new